Professional Documents
Culture Documents
Asthma Case Study Answers 20jan 202011 Web Module2 PDF
Asthma Case Study Answers 20jan 202011 Web Module2 PDF
Mr Thomson, a 32 year old asthmatic who is well known to you comes into your pharmacy.
He is known to have a best peak flow of 640 L/min. He tells you that over the last few weeks
he has been wakening up once or twice a week coughing, and he is using his salbutamol
inhaler a couple of times a day. He has recorded his morning and night-time peak flows
these have averaged 580 L/min and 540L/min respectively. He has recently changed his job
and is now working in the open air rather than in an office.
for the last four years. He also buys antihistamine tablets from you during the summer.
®
His prescription today is for a Seretide MDI 50 2 puffs twice a day.
Based on the information available construct a care plan for this patient. He is under
pharmacist care for his asthma.
Include in the plan the immediate management of the patient and the monitoring you
would carry out to ensure that the patient is benefiting from your plan.
The immediate management needs of this patient relate to the step up of his asthma
medication caused by the loss of control of his asthma. The patient has uncontrolled
asthma but his PEFR is between 84 and 90% of predicted. The other signs of
uncontrolled / poorly controlled asthma are the night-time wakening and cough.
Include in your plan any monitoring for the patient and any suggested changes in
therapy. What would you use as criteria for referral of this patient to the GP or
secondary care?
The criteria for referral would be deterioration in his asthma control rather than a
slight improvement. The same asthma question could be asked to decide when the
patient is referred
What would you include in his care plan now? Could Mr Thomson be managed in the
community or does he need to be admitted to hospital?
The patient is showing signs of acute severe asthma – PEFR is approx 60% of best. This
patient’s immediate symptoms could be managed in the community by using multiple puffs
of a MDI in a spacer. Each puff should be inhaled before the next puff is put into the
spacer. The patient could also be given prednisolone in the community. If the patient
requires oxygen it may be difficult to administer this in the community.
If the patient does not respond to the initial SABA and prednisolone in the community
they should be admitted to hospital.
You are asked to dispense a prescription for Angela, age 10 years, for
Angela has been a patient of your pharmacy since she was a small child and has suffered
from eczema and hay fever since she was 3 years old. Two years ago she was diagnosed
with asthma and her GP has commenced this prescription. You know that she has been
referred to the local hospital to see the respiratory paediatrician as her asthma was not
controlled on Seretide 50, 2 puffs twice a day. She saw the hospital paediatric respiratory
consultant last week.
In the care plan you should include prescribing, monitoring and follow-up for Angela.
Indicate when you would expect to see her again and how often she should attend for
follow-up. What other health-care professionals would you involve in the care of this
patient?
The aims of asthma management are the same for children as they are for adults. In
this case the care plan should take into consideration Angela’s other problems of eczema
and hayfever. These are atopic conditions and may be associated with asthma in
children.
Angela is discharged from hospital following an acute exacerbation she is now prescribed
salbutamol MDI 2 puffs as required
Seretide® 125 Evohaler 2 puffs twice daily
prednisolone 50mg 3 days to complete a 5 day course
How would you alter the care plan for Angela following her hospital admission? Does
this change the monitoring and follow-up for the child?
• The basic care plan remains the same in terms of monitoring growth and
compliance.
• Ensure that the Seretide Evohaler is prescribed correctly – this dose is above
the recommended dose for a child and should only be used on the advice of a
specialist in paediatric respiratory medicine. Just being in hospital does not
ensure this. A plan for monitoring and ensuring that the dose is reduced when
appropriate needs to be pt in place
• Ensure that the prednisolone is stopped after the short course and that it does
not get repeated.
• Ensure that a steroid warning card is issued to the child’s parents and that they
are aware of the need to point out to other heath care professionals that Angela
is on steroids. This is appropriate for the higher dose steroid inhaler as well as
the oral prednisolone
• Ensure that Angela is followed up about a week after discharge and the
prescription reviewed.
Case 3
Mrs White, a 35 year old woman who is 28 weeks pregnant, comes in to your pharmacy on a
Saturday afternoon with a repeat prescription for a terbutaline turbohaler. She last received a
prescription for terbutaline 10 days ago and on that occasion received 2 turbohalers.
From your PMR you note that at the same time she was also prescribed
Symbicort® 100/6 Turbohaler 2 doses twice daily
On questioning Mrs White regarding her symptoms she says her asthma is usually worse at
this time of year. She has used her last two terbutaline turbohalers and that although you
dispensed the Symbicort® she has not been using these for the last six months as she was
concerned about the effect that the corticosteroids may have on her unborn child. She has
been using up all the terbutaline inhalers that she had at home and is now wheezy
What is the immediate care that Mrs White requires? How can this be delivered?
Construct a care plan for Mrs White to deal with her breathlessness. Include in this
recommendations for prescribing and monitoring
The immediate care for the patient does not involve drawing up a care plan but dealing
with the medical emergency that you have in front of you. The patient has used two
turbohalers in the last 10 days well over the recommended dose and shows that she has
uncontrolled asthma. She is using about 20 doses of SABA a day.
Over the past months the care plan for this patient should have contained
• Ensure that the patient is still taking her ICS and LABA. The risk to the unborn
child of uncontrolled asthma is greater than the risk of the ICS and LABA.
• Ensure that the patient understands the need for her asthma to be well
controlled to ensure that the baby is healthy.
• Monitor the patient in the same way as any other asthma patient by using the 5
questions on the care plan to ensure that she is well controlled.
• The high use of the SABA inhaler should have prompted a review of this patient
and an early discussion about her asthma
• The most important part of this patients care plan is the counselling
• Ensure that the patient understands the need to take the oral steroid and the
ICS to ensure asthma control. This counselling may take some time to
o explain the nature of asthma and the need for the inhaled and oral
steroids,
o the nature of drug delivery to the lungs and the small amounts absorbed
from here into the systemic circulation
o the problems associated with poor oxygen supply to the unborn baby
o there is no evidence that the ICS and LABA have any effect on the
unborn baby
o the use of the OCS for short term use is not known to have any effect
on the unborn baby
o the risks of the asthma are greater than the risks of the medication
• Ensure that the OCS is a short course only and that it is not repeated
• Ensure that the patient is given a steroid warning card but explain that the risks
of the side effects are small
• Monitor the patients improvement by giving her a diary card to record her PEFR,
use of SABA and other symptoms